Practical Considerations to Extend Treatment for VTE

VTE Acute, Long-Term, and Extended Treatment

Provoked VTE

Unprovoked VTE

Men Are at Higher Risk of VTE Than Are Women

HERDOO2 Rule

VTE Extension Trials: NOACs vs Placebo

Extending Anticoagulation

Bleeding

ASPIRIN: WARFASA and INSPIRE

EINSTEIN Choice Study Design

EINSTEIN Choice Primary Outcome -- Recurrent VTE

EINSTEIN Choice Bleeding Outcomes

EINSTEIN Choice: Provoked, Unprovoked, and History of VTE

AMPLIFY-EXT Efficacy and Safety

NOACs in Prevention of Cancer-Associated VTE

Adherence

Timing of Doses

Anticoagulation and Need for Antiplatelet Therapy

Summary

Abbreviations